Does renal ageing affect survival?

Ageing Research Reviews

Volumn 6, Issue 3, 2007, Pages 211-222

  Razzaque, M Shawkat ^a  

^a HARVARD SCHOOL OF DENTAL MEDICINE   (United States)

Author keywords

Ageing; Caloric restriction; Growth hormone; Insulin like growth factor 1; Nephropathy

Indexed keywords

GROWTH HORMONE; SOMATOMEDIN C;

AGING; CALORIC RESTRICTION; CELL INFILTRATION; DIET; GLOMERULOSCLEROSIS; HORMONE ACTION; HUMAN; INFLAMMATORY CELL; KIDNEY; KIDNEY DISEASE; KIDNEY FIBROSIS; KIDNEY FUNCTION; KIDNEY INJURY; LONGEVITY; NONHUMAN; SHORT SURVEY; SURVIVAL;

AGING; ANIMALS; FOOD DEPRIVATION; GLYCOSYLATION END PRODUCTS, ADVANCED; GROWTH HORMONE; HUMANS; INSULIN-LIKE GROWTH FACTOR I; KIDNEY; KIDNEY DISEASES; KIDNEY TUBULES; LONGEVITY; OXIDATIVE STRESS;

ANIMALIA;

EID: 34548666429     PISSN: 15681637     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.arr.2007.06.001     Document Type: Short Survey

References (104)

1. Abid M.R., Razzaque M.S., and Taguchi T. Oxidant stress in renal pathophysiology. Contrib. Nephrol. 148 (2005) 135-153
2. Adler S., Huang H., Wolin M.S., and Kaminski P.M. Oxidant stress leads to impaired regulation of renal cortical oxygen consumption by nitric oxide in the aging kidney. J. Am. Soc. Nephrol. 15 (2004) 52-60
3. Azouz A., Razzaque M.S., El-Hallak M., and Taguchi T. Immunoinflammatory responses and fibrogenesis. Med. Electron. Microsc. 37 (2004) 141-148
4. Baylis C. Age-dependent glomerular damage in the rat. Dissociation between glomerular injury and both glomerular hypertension and hypertrophy. Male gender as a primary risk factor. J. Clin. Invest. 94 (1994) 1823-1829
5. Baylis C., and Schmidt R. The aging glomerulus. Semin. Nephrol. 16 (1996) 265-276
6. Bedossa P., and Paradis V. Transforming growth factor-beta (TGF-beta): a key-role in liver fibrogenesis. J. Hepatol. 22 (1995) 37-42
7. Bengele H.H., Mathias R., Perkins J.H., McNamara E.R., and Alexander E.A. Impaired renal and extrarenal potassium adaptation in old rats. Kidney Int. 23 (1983) 684-690
8. Castilla A., and Prieto J. Human fibrogenesis and transforming growth factor beta-1. J. Hepatol. 18 (1993) 378-379
9. Chen N.Y., Chen W.Y., Bellush L., Yang C.W., Striker L.J., Striker G.E., and Kopchick J.J. Effects of streptozotocin treatment in growth hormone (GH) and GH antagonist transgenic mice. Endocrinology 136 (1995) 660-667
10. Chen W.Y., Chen N., Yun J., Wagner T.E., and Kopchick J.J. In vitro and in vivo studies of the antagonistic effects of human growth hormone analogs. J. Biol. Chem. 269 (1994) 20806
11. Chen W.Y., Chen N.Y., Yun J., Wagner T.E., and Kopchick J.J. In vitro and in vivo studies of antagonistic effects of human growth hormone analogs. J. Biol. Chem. 269 (1994) 15892-15897
12. Cho C.G., Kim H.J., Chung S.W., Jung K.J., Shim K.H., Yu B.P., Yodoi J., and Chung H.Y. Modulation of glutathione and thioredoxin systems by calorie restriction during the aging process. Exp. Gerontol. 38 (2003) 539-548
13. Chung H.Y., Song S.H., Kim H.J., Ikeno Y., and Yu B.P. Modulation of renal xanthine oxidoreductase in aging: gene expression and reactive oxygen species generation. J. Nutr. Health Aging 3 (1999) 19-23
14. Cooke J.P. Does ADMA cause endothelial dysfunction?. Arterioscler. Thromb. Vasc. Biol. 20 (2000) 2032-2037
15. Coresh J., Astor B.C., Greene T., Eknoyan G., and Levey A.S. Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey. Am. J. Kidney Dis. 41 (2003) 1-12
16. Csiszar A., Ungvari Z., Edwards J.G., Kaminski P., Wolin M.S., Koller A., and Kaley G. Aging-induced phenotypic changes and oxidative stress impair coronary arteriolar function. Circ. Res. 90 (2002) 1159-1166
17. Cullen-McEwen L.A., Kett M.M., Dowling J., Anderson W.P., and Bertram J.F. Nephron number, renal function, and arterial pressure in aged GDNF heterozygous mice. Hypertension 41 (2003) 335-340
18. Doi T., Striker L.J., Gibson C.C., Agodoa L.Y., Brinster R.L., and Striker G.E. Glomerular lesions in mice transgenic for growth hormone and insulinlike growth factor-I I. Relationship between increased glomerular size and mesangial sclerosis. Am. J. Pathol. 137 (1990) 541-552
19. Doublier S., Seurin D., Fouqueray B., Verpont M.C., Callard P., Striker L.J., Striker G.E., Binoux M., and Baud L. Glomerulosclerosis in mice transgenic for human insulin-like growth factor-binding protein-1. Kidney Int. 57 (2000) 2299-2307
20. Ebbesen J., Buajordet I., Erikssen J., Brors O., Hilberg T., Svaar H., and Sandvik L. Drug-related deaths in a department of internal medicine. Arch. Intern. Med. 161 (2001) 2317-2323
21. Editorial. Do doctors short-change old people?. Lancet 342 (1993) 1-2
22. Eggers P.W., Frankenfield D.L., Greer J.W., McClellan W., Owen Jr. W.F., and Rocco M.V. Comparison of mortality and intermediate outcomes between medicare dialysis patients in HMO and fee for service. Am. J. Kidney Dis. 39 (2002) 796-804
23. Finkel T., and Holbrook N.J. Oxidants, oxidative stress and the biology of ageing. Nature 408 (2000) 239-247
24. Francois V., Heudes D., Bariety J., Bruneval P., and Corman B. Glomerular capillary network of cortical nephrons is reduced in male but not in female aging rats. Mech. Ageing Dev. 91 (1996) 11-22
25. Gay E., Seurin D., Babajko S., Doublier S., Cazillis M., and Binoux M. Liver-specific expression of human insulin-like growth factor binding protein-1 in transgenic mice: repercussions on reproduction, ante- and perinatal mortality and postnatal growth. Endocrinology 138 (1997) 2937-2947
26. Goettsch W., Lattmann T., Amann K., Szibor M., Morawietz H., Munter K., Muller S.P., Shaw S., and Barton M. Increased expression of endothelin-1 and inducible nitric oxide synthase isoform II in aging arteries in vivo: implications for atherosclerosis. Biochem. Biophys. Res. Commun. 280 (2001) 908-913
27. Gourtsoyiannis N., Prassopoulos P., Cavouras D., and Pantelidis N. The thickness of the renal parenchyma decreases with age: a CT study of 360 patients. Am. J. Roentgenol. 155 (1990) 541-544
28. Hajjar I., and Kotchen T.A. Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988-2000. JAMA 290 (2003) 199-206
29. Hamilton M.L., Van Remmen H., Drake J.A., Yang H., Guo Z.M., Kewitt K., Walter C.A., and Richardson A. Does oxidative damage to DNA increase with age?. Proc. Natl. Acad. Sci. U.S.A. 98 (2001) 10469-10474
30. Harman D. Aging: a theory based on free radical and radiation chemistry. J. Gerontol. 11 (1956) 298-300
31. Harman D. Aging: overview. Ann. NY Acad. Sci. 928 (2001) 1-21
32. Hekimi S., and Guarente L. Genetics and the specificity of the aging process. Science 299 (2003) 1351-1354
33. Holzenberger M., Dupont J., Ducos B., Leneuve P., Geloen A., Even P.C., Cervera P., and Le Bouc Y. IGF-1 receptor regulates lifespan and resistance to oxidative stress in mice. Nature 421 (2003) 182-187
34. Hsu C.C., Bray M.S., Kao W.H., Pankow J.S., Boerwinkle E., and Coresh J. Genetic variation of the renin-angiotensin system and chronic kidney disease progression in black individuals in the atherosclerosis risk in communities study. J. Am. Soc. Nephrol. 17 (2006) 504-512
35. Kasiske B.L. Relationship between vascular disease and age-associated changes in the human kidney. Kidney Int. 31 (1987) 1153-1159
36. Kielstein J.T., Bode-Boger S.M., Frolich J.C., Ritz E., Haller H., and Fliser D. Asymmetric dimethylarginine, blood pressure, and renal perfusion in elderly subjects. Circulation 107 (2003) 1891-1895
37. Kielstein J.T., Bode-Boger S.M., Haller H., and Fliser D. Functional changes in the ageing kidney: is there a role for asymmetric dimethylarginine?. Nephrol. Dial. Transplant. 18 (2003) 1245-1248
38. Kielstein J.T., Boger R.H., Bode-Boger S.M., Frolich J.C., Haller H., Ritz E., and Fliser D. Marked increase of asymmetric dimethylarginine in patients with incipient primary chronic renal disease. J. Am. Soc. Nephrol. 13 (2002) 170-176
39. Kim H.J., Yu B.P., and Chung H.Y. Molecular exploration of age-related NF-kappaB/IKK downregulation by calorie restriction in rat kidney. Free Radic. Biol. Med. 32 (2002) 991-1005
40. Kingswood J.C., Banks R.A., Tribe C.R., Owen-Jones J., and Mackenzie J.C. Renal biopsy in the elderly: clinicopathological correlations in 143 patients. Clin. Nephrol. 22 (1984) 183-187
41. Kujoth G.C., Hiona A., Pugh T.D., Someya S., Panzer K., Wohlgemuth S.E., Hofer T., Seo A.Y., Sullivan R., Jobling W.A., Morrow J.D., Van Remmen H., Sedivy J.M., Yamasoba T., Tanokura M., Weindruch R., Leeuwenburgh C., and Prolla T.A. Mitochondrial DNA mutations, oxidative stress, and apoptosis in mammalian aging. Science 309 (2005) 481-484
42. Kuro-o M., Matsumura Y., Aizawa H., Kawaguchi H., Suga T., Utsugi T., Ohyama Y., Kurabayashi M., Kaname T., Kume E., Iwasaki H., Iida A., Shiraki-Iida T., Nishikawa S., Nagai R., and Nabeshima Y.I. Mutation of the mouse klotho gene leads to a syndrome resembling ageing. Nature 390 (1997) 45-51
43. Lanske B., and Razzaque M.S. Mineral metabolism and aging: the FGF-23 enigma. Curr. Opin. Nephrol. Hypertens. 16 (2007) 311-318
44. Lanske B., and Razzaque M.S. Premature aging in klotho mutant mice: cause or consequence?. Ageing Res. Rev. 6 (2007) 73-79
45. Li Y.M., Steffes M., Donnelly T., Liu C., Fuh H., Basgen J., Bucala R., and Vlassara H. Prevention of cardiovascular and renal pathology of aging by the advanced glycation inhibitor aminoguanidine. Proc. Natl. Acad. Sci. U.S.A. 93 (1996) 3902-3907
46. Ma L.J., and Fogo A.B. Model of robust induction of glomerulosclerosis in mice: importance of genetic background. Kidney Int. 64 (2003) 350-355
47. Marciniak R., and Guarente L. Human genetics. Testing telomerase. Nature 413 (2001) 370-1, 373
48. Martin J.E., and Sheaff M.T. Renal ageing. J. Pathol. 211 (2007) 198-205
49. Masoro E.J. Aging and nutrition-can diet affect life span?. Trans. Assoc. Life Insur. Med. Dir. Am. 67 (1985) 30-44
50. Masoro E.J. How does dietary restriction alter aging and survival in rodents?. Aging (Milano) 3 (1991) 384-386
51. Masoro E.J. Retardation of aging processes by food restriction: an experimental tool. Am. J. Clin. Nutr. 55 (1992) 1250S-1252S
52. Masoro E.J., Iwasaki K., Gleiser C.A., McMahan C.A., Seo E.J., and Yu B.P. Dietary modulation of the progression of nephropathy in aging rats: an evaluation of the importance of protein. Am. J. Clin. Nutr. 49 (1989) 1217-1227
53. McKiernan S.H., Tuen V.C., Baldwin K., Wanagat J., Djamali A., and Aiken J.M. Adult-onset calorie restriction delays the accumulation of mitochondrial enzyme abnormalities in aging rat kidney tubular epithelial cells. Am. J. Physiol. Renal. Physiol. 292 (2007) F1751-F1760
54. McLachlan M., and Wasserman P. Changes in sizes and distensibility of the aging kidney. Br. J. Radiol. 54 (1981) 488-491
55. McLean A.J., and Le Couteur D.G. Aging biology and geriatric clinical pharmacology. Pharmacol. Rev. 56 (2004) 163-184
56. Mitani H., Ishizaka N., Aizawa T., Ohno M., Usui S., Suzuki T., Amaki T., Mori I., Nakamura Y., Sato M., Nangaku M., Hirata Y., and Nagai R. In vivo klotho gene transfer ameliorates angiotensin II-induced renal damage. Hypertension 39 (2002) 838-843
57. Miyazaki H., Matsuoka H., Itabe H., Usui M., Ueda S., Okuda S., and Imaizumi T. Hemodialysis impairs endothelial function via oxidative stress: effects of vitamin E-coated dialyzer. Circulation 101 (2000) 1002-1006
58. Moorthy A.V., and Zimmerman S.W. Renal disease in the elderly: clinicopathologic analysis of renal disease in 115 elderly patients. Clin. Nephrol. 14 (1980) 223-229
59. Nzerue C.M., Hewan-Lowe K., and Nwawka C. Acute renal failure in pregnancy: a review of clinical outcomes at an inner-city hospital from 1986 to 1996. J. Natl. Med. Assoc. 90 (1998) 486-490
60. Obialo C.I., and Hewan-Lowe K. Rapid progression to end-stage renal disease in young hypertensive African Americans with proteinuria. J. Natl. Med. Assoc. 90 (1998) 649-655
61. Owen R.A., and Heywood R. Age-related variations in renal structure and function in Sprague-Dawley rats. Toxicol. Pathol. 14 (1986) 158-167
62. Port F.K. Description and clinical outcomes of peritoneal dialysis: analyses from the United States Renal Data System. Perit. Dial. Int. 20 Suppl. 2 (2000) S114-S117
63. Razzaque M.S., Koji T., Taguchi T., Harada T., and Nakane P.K. In situ localization of type III and type IV collagen-expressing cells in human diabetic nephropathy. J. Pathol. 174 (1994) 131-138
64. Razzaque M.S., Kumatori A., Harada T., and Taguchi T. Coexpression of collagens and collagen-binding heat shock protein 47 in human diabetic nephropathy and IgA nephropathy. Nephron 80 (1998) 434-443
65. Razzaque M.S., and Lanske B. Hypervitaminosis D and premature aging: lessons learned from Fgf23 and Klotho mutant mice. Trends Mol. Med. 12 (2006) 298-305
66. Razzaque M.S., and Lanske B. The emerging role of the fibroblast growth factor-23-klotho axis in renal regulation of phosphate homeostasis. J. Endocrinol. 194 (2007) 1-10
67. Razzaque M.S., Le V.T., and Taguchi T. Heat shock protein 47 and renal fibrogenesis. Contrib. Nephrol. 148 (2005) 57-69
68. Razzaque M.S., Shimokawa I., Koji T., Higami Y., and Taguchi T. Life-long caloric restriction suppresses age-associated Fas expression in the Fischer 344 rat kidney. Mol. Cell Biol. Res. Commun. 1 (1999) 82-85
69. Razzaque M.S., Shimokawa I., Nazneen A., Higami Y., and Taguchi T. Age-related nephropathy in the Fischer 344 rat is associated with overexpression of collagens and collagen-binding heat shock protein 47. Cell Tissue Res. 293 (1998) 471-478
70. Razzaque M.S., Shimokawa I., Nazneen A., Liu D., Naito T., Higami Y., and Taguchi T. Life-long dietary restriction modulates the expression of collagens and collagen-binding heat shock protein 47 in aged Fischer 344 rat kidney. Histochem. J. 31 (1999) 123-132
71. Razzaque M.S., Sitara D., Taguchi T., St-Arnaud R., and Lanske B. Premature aging-like phenotype in fibroblast growth factor 23 null mice is a vitamin D-mediated process. FASEB J. 20 (2006) 720-722
72. Razzaque M.S., and Taguchi T. Collagen-binding heat shock protein (HSP) 47 expression in anti-thymocyte serum (ATS)-induced glomerulonephritis. J. Pathol. 183 (1997) 24-29
73. Razzaque M.S., and Taguchi T. The possible role of colligin/HSP47, a collagen-binding protein, in the pathogenesis of human and experimental fibrotic diseases. Histol. Histopathol. 14 (1999) 1199-1212
74. Razzaque M.S., and Taguchi T. Role of glomerular epithelial cell-derived heat shock protein 47 in experimental lipid nephropathy. Kidney Int. Suppl. 71 (1999) S256-S259
75. Razzaque M.S., and Taguchi T. Cellular and molecular events leading to renal tubulointerstitial fibrosis. Med. Electron. Microsc. 35 (2002) 68-80
76. Razzaque M.S., and Taguchi T. Factors that influence and contribute to the regulation of fibrosis. Contrib. Nephrol. 139 (2003) 1-11
77. Rivard A., Fabre J.E., Silver M., Chen D., Murohara T., Kearney M., Magner M., Asahara T., and Isner J.M. Age-dependent impairment of angiogenesis. Circulation 99 (1999) 111-120
78. Rodwell G.E., Sonu R., Zahn J.M., Lund J., Wilhelmy J., Wang L., Xiao W., Mindrinos M., Crane E., Segal E., Myers B.D., Brooks J.D., Davis R.W., Higgins J., Owen A.B., and Kim S.K. A transcriptional profile of aging in the human kidney. PLoS Biol. 2 (2004) e427
79. Rowe J.W., Andres R., Tobin J.D., Norris A.H., and Shock N.W. The effect of age on creatinine clearance in men: a cross-sectional and longitudinal study. J. Gerontol. 31 (1976) 155-163
80. Roxe D.M. Renal function, aging, and drug therapy. Compr. Ther. 15 (1989) 13-18
81. Rudolph K.L., Chang S., Lee H.W., Blasco M., Gottlieb G.J., Greider C., and DePinho R.A. Longevity, stress response, and cancer in aging telomerase-deficient mice. Cell 96 (1999) 701-712
82. Ruiz-Torres M.P., Bosch R.J., O'Valle F., Del Moral R.G., Ramirez C., Masseroli M., Perez-Caballero C., Iglesias M.C., Rodriguez-Puyol M., and Rodriguez-Puyol D. Age-related increase in expression of TGF-beta1 in the rat kidney: relationship to morphologic changes. J. Am. Soc. Nephrol. 9 (1998) 782-791
83. Shimokawa I., Higami Y., Hubbard G.B., McMahan C.A., Masoro E.J., and Yu B.P. Diet and the suitability of the male Fischer 344 rat as a model for aging research. J. Gerontol. 48 (1993) B27-B32
84. Shimokawa I., Higami Y., Tsuchiya T., Otani H., Komatsu T., Chiba T., and Yamaza H. Life span extension by reduction of the growth hormone-insulin-like growth factor-1 axis: relation to caloric restriction. FASEB J. 17 (2003) 1108-1109
85. Shimokawa I., Higami Y., Utsuyama M., Tuchiya T., Komatsu T., Chiba T., and Yamaza H. Life span extension by reduction in growth hormone-insulin-like growth factor-1 axis in a transgenic rat model. Am. J. Pathol. 160 (2002) 2259-2265
86. Silva F.G. The aging kidney: a review, Part I. Int. Urol. Nephrol. 37 (2005) 185-205
87. Silva F.G. The aging kidney: a review, Part II. Int. Urol. Nephrol. 37 (2005) 419-432
88. Sohal R.S., Agarwal S., Candas M., Forster M.J., and Lal H. Effect of age and caloric restriction on DNA oxidative damage in different tissues of C57BL/6 mice. Mech. Ageing Dev. 76 (1994) 215-224
89. Sohal R.S., and Weindruch R. Oxidative stress, caloric restriction, and aging. Science 273 (1996) 59-63
90. Sonntag W.E., Carter C.S., Ikeno Y., Ekenstedt K., Carlson C.S., Loeser R.F., Chakrabarty S., Lee S., Bennett C., Ingram R., Moore T., and Ramsey M. Adult-onset growth hormone and insulin-like growth factor I deficiency reduces neoplastic disease, modifies age-related pathology, and increases life span. Endocrinology 146 (2005) 2920-2932
91. Sonntag W.E., Ramsey M., and Carter C.S. Growth hormone and insulin-like growth factor-1 (IGF-1) and their influence on cognitive aging. Ageing Res. Rev. 4 (2005) 195-212
92. Stuhlinger M.C., Abbasi F., Chu J.W., Lamendola C., McLaughlin T.L., Cooke J.P., Reaven G.M., and Tsao P.S. Relationship between insulin resistance and an endogenous nitric oxide synthase inhibitor. JAMA 287 (2002) 1420-1426
93. Sutherland J.W., Parks J.H., and Coe F.L. Recurrence after a single renal stone in a community practice. Miner. Electrolyte Metab. 11 (1985) 267-269
94. Taguchi T., and Razzaque M.S. The collagen-specific molecular chaperone HSP47: is there a role in fibrosis?. Trends Mol. Med. 13 (2007) 45-53
95. Tanaka T., Kato H., Kojima I., Ohse T., Son D., Tawakami T., Yatagawa T., Inagi R., Fujita T., and Nangaku M. Hypoxia and expression of hypoxia-inducible factor in the aging kidney. J. Gerontol. A: Biol. Sci. Med. Sci. 61 (2006) 795-805
96. Tauchi H., Tsuboi K., and Okutomi J. Age changes in the human kidney of the different races. Gerontologia 17 (1971) 87-97
97. Teillet L., Verbeke P., Gouraud S., Bakala H., Borot-Laloi C., Heudes D., Bruneval P., and Corman B. Food restriction prevents advanced glycation end product accumulation and retards kidney aging in lean rats. J. Am. Soc. Nephrol. 11 (2000) 1488-1497
98. Wagner B.M. Renal pathology and aging. Hum. Pathol. 18 (1987) 659-660
99. Xiong Y., Yuan L.W., Deng H.W., Li Y.J., and Chen B.M. Elevated serum endogenous inhibitor of nitric oxide synthase and endothelial dysfunction in aged rats. Clin. Exp. Pharmacol. Physiol. 28 (2001) 842-847
100. Yu B.P., Masoro E.J., Murata I., Bertrand H.A., and Lynd F.T. Life span study of SPF Fischer 344 male rats fed ad libitum or restricted diets: longevity, growth, lean body mass and disease. J. Gerontol. 37 (1982) 130-141
101. Yumura W., Imasawa T., Suganuma S., Ishigami A., Handa S., Kubo S., Joh K., and Maruyama N. Accelerated tubular cell senescence in SMP30 knockout mice. Histol. Histopathol. 21 (2006) 1151-1156
102. Yumura W., Sugino N., Nagasawa R., Kubo S., Hirokawa K., and Maruyama N. Age-associated changes in renal glomeruli of mice. Exp. Gerontol. 24 (1989) 237-249
103. Zha Y., Le V.T., Higami Y., Shimokawa I., Taguchi T., and Razzaque M.S. Life-long suppression of growth hormone-insulin-like growth factor I activity in genetically altered rats could prevent age-related renal damage. Endocrinology 147 (2006) 5690-5698
104. Zhang C., Liu V.W., Addessi C.L., Sheffield D.A., Linnane A.W., and Nagley P. Differential occurrence of mutations in mitochondrial DNA of human skeletal muscle during aging. Hum. Mutat. 11 (1998) 360-371